Analysis Writedowns and growing pains ahead for Tilray 2.0, analyst says But Chris Damas of the BCMI Cannabis Report notes the Aphria-merged firm will command a strong presence in Europe's medical cannabis market Jared GnamMay 3, 2021
Industry update Canopy buying Supreme Cannabis for $435M in premium brand grab Analysts question whether consumers will stay loyal to 7Acres under Canopy's stewardship Jared GnamApril 8, 2021
Analysis 48North cuts outdoor production, 20% of staff Ontario producer's Good Farm likely wasn't even covering labour costs amid nationwide supply gluts, says BCMI Cannabis Report Jared GnamMarch 29, 2021
Industry update Organigram shares sink as sales shrink High-cost cultivation without premium brands is a losing combo for the New Brunswick producer, analyst says Jared GnamJanuary 12, 2021
Analysis Ontario speeds up cannabis retail approvals again amid applicant frustration But approving 80 retail licences a month will lead to saturation in some regions, according to BCMI analyst Chris Damas Jared GnamDecember 9, 2020
Analysis Pot stock leaders to consider ahead of US election: BCMI Analyst Chris Damas gives investors his industry leaders in Canada and the U.S., which could win big if Democrats take power Jared GnamOctober 28, 2020
Analysis Croptober 2020: Why a tsunami of Canadian outdoor will go up in smoke Supply gluts, collapsing wholesale prices and Canadian regulations put an incoming 360,000 kgs of outdoor weed at risk of going unsold Jared GnamOctober 20, 2020